FDA Will Exercise Enforcement Discretion On Pedigrees
This article was originally published in The Pink Sheet Daily
Executive Summary
The agency will require pedigrees to trace transactions back to the authorized distributor of record while a preliminary injunction is in effect.
You may also be interested in...
GSK Warns Pharmacists Of Ziagen, Combivir Mix Up
FDA issues a MedWatch alert April 10 advising of misbranded bottles of the HIV drug Combivir containing Ziagen instead.
GSK Warns Pharmacists Of Ziagen, Combivir Mix Up
FDA issues a MedWatch alert April 10 advising of misbranded bottles of the HIV drug Combivir containing Ziagen instead.
Drug Pedigree Rule In Doubt
Federal court issues preliminary injunction barring FDA from enforcing the PDMA pedigree final rule.